Neurotrophin receptor tyrosine kinases regulated with near-infrared light

被引:54
作者
Leopold, Anna V. [1 ]
Chernov, Konstantin G. [1 ]
Shemetov, Anton A. [2 ,3 ]
Verkhusha, Vladislav V. [1 ,2 ,3 ]
机构
[1] Univ Helsinki, Medicum, Fac Med, FIN-00290 Helsinki, Finland
[2] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA
基金
美国国家卫生研究院;
关键词
CELL-DEATH; FLUORESCENT PROTEINS; TRKA; ACTIVATION; BIOSENSORS; TOOLS; ERK;
D O I
10.1038/s41467-019-08988-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Optical control over the activity of receptor tyrosine kinases (RTKs) provides an efficient way to reversibly and non-invasively map their functions. We combined catalytic domains of Trk (tropomyosin receptor kinase) family of RTKs, naturally activated by neurotrophins, with photosensory core module of DrBphP bacterial phytochrome to develop opto-kinases, termed Dr-TrkA and Dr-TrkB, reversibly switchable on and off with near-infrared and far-red light. We validated Dr-Trk ability to reversibly light-control several RTK pathways, calcium level, and demonstrated that their activation triggers canonical Trk signaling. Dr-TrkA induced apoptosis in neuroblastoma and glioblastoma, but not in other cell types. Absence of spectral crosstalk between Dr-Trks and blue-light-activatable LOV-domain-based translocation system enabled intracellular targeting of Dr-TrkA independently of its activation, additionally modulating Trk signaling. Dr-Trks have several superior characteristics that make them the opto-kinases of choice for regulation of RTK signaling: high activation range, fast and reversible photoswitching, and multiplexing with visible-light-controllable optogenetic tools.
引用
收藏
页数:13
相关论文
共 35 条
[1]   RETRACTED: Origin of the U87MG glioma cell line: Good news and bad news (Retracted article. See vol. 19, 2024) [J].
Allen, Marie ;
Bjerke, Mia ;
Edlund, Hanna ;
Nelander, Sven ;
Westermark, Bengt .
SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (354)
[2]  
Balla T, 2009, CURR PROTOC CELL BIO, V42
[3]   The Crystal Structures of TrkA and TrkB Suggest Key Regions for Achieving Selective Inhibition [J].
Bertrand, T. ;
Kothe, M. ;
Liu, J. ;
Dupuy, A. ;
Rak, A. ;
Berne, P. F. ;
Davis, S. ;
Gladysheva, T. ;
Valtre, C. ;
Crenne, J. Y. ;
Mathieu, M. .
JOURNAL OF MOLECULAR BIOLOGY, 2012, 423 (03) :439-453
[4]   Unnatural ligands for engineered proteins: New tools for chemical genetics [J].
Bishop, A ;
Buzko, O ;
Heyeck-Dumas, S ;
Jung, I ;
Kraybill, B ;
Liu, Y ;
Shah, K ;
Ulrich, S ;
Witucki, L ;
Yang, F ;
Zhang, C ;
Shokat, KM .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2000, 29 :577-606
[5]   Light-inducible receptor tyrosine kinases that regulate neurotrophin signalling [J].
Chang, Ki-Young ;
Woo, Doyeon ;
Jung, Hyunjin ;
Lee, Sangkyu ;
Kim, Sungsoo ;
Won, Joungha ;
Kyung, Taeyoon ;
Park, Hyerim ;
Kim, Nury ;
Yang, Hee Won ;
Park, Jae-Yong ;
Hwang, Eun Mi ;
Kim, Daesoo ;
Do Heo, Won .
NATURE COMMUNICATIONS, 2014, 5
[6]   Near-Infrared Fluorescent Proteins, Biosensors, and Optogenetic Tools Engineered from Phytochromes [J].
Chernov, Konstantin G. ;
Redchuk, Taras A. ;
Omelina, Evgeniya S. ;
Verkhushaa, Vladislav V. .
CHEMICAL REVIEWS, 2017, 117 (09) :6423-6446
[7]   Kinase chemical genomics - a new rule for the exceptions [J].
Cravatt, BF .
NATURE METHODS, 2005, 2 (06) :411-412
[8]   CREB: A major mediator of neuronal neurotrophin responses [J].
Finkbeiner, S ;
Tavazoie, SF ;
Maloratsky, A ;
Jacobs, KM ;
Harris, KM ;
Greenberg, ME .
NEURON, 1997, 19 (05) :1031-1047
[9]   Engineering of a red-light-activated human cAMP/cGMP-specific phosphodiesterase [J].
Gasser, Carlos ;
Taiber, Sandra ;
Yeh, Chen-Min ;
Wittig, Charlotte Helene ;
Hegemann, Peter ;
Ryu, Soojin ;
Wunder, Frank ;
Moeglich, Andreas .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (24) :8803-8808
[10]   Live or Let Die: CCM2 Provides the Link [J].
Gruber-Olipitz, Mariella ;
Segal, Rosalind A. .
NEURON, 2009, 63 (05) :559-560